No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Zhejiang Shouxiangu Pharmaceutical Co., Ltd., founded in 1997 and based in Jinhua, China, is dedicated to the investigation, creation, and commercialization of traditional Chinese medicine preparations. Their extensive product line features prominent items such as ganoderma lucidum spore powder, dendrobium officinale, and crocus sativus, among various other wellness-focused offerings.
www.sxg1909.comNo one on the platform currently holds 603896.SS.
No tracked institution reports a position in 603896.SS as of their last filing.
No one on the platform has traded 603896.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 1.1% | 14.7% | 14.2% | — | — | — |
| Rev. Growth % | -7.4% | 0.1% | ||||
| Profit Margin % | 2.8% | 24.0% | 23.8% | |||
| Free Cash Flow Margin % | -7.1% | -5.1% | 5.3% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $656M | -13.3% | $0.54 | $0.52–$0.56 | — | 2 |
| 2027 | $706M | +7.6% | $0.69 | $0.69–$0.69 | — | 1 |
| 2028 | $759M | +7.5% | $0.81 | $0.81–$0.81 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 603896.SSZhejiang Shouxiangu Pharmaceutical Co., Ltd. | $14.03 | -0.36% | $2.8B | — |
| 002286.SZBaolingbao Biology Co.,Ltd. | $7.69 | +0.26% | $2.9B | — |
| 300653.SZYantai Zhenghai Biotechnology Co., Ltd. | $14.58 | +0.55% | $2.6B | — |
| 300871.SZHvsen Biotechnology Co., Ltd. | $21.56 | +1.13% | $4.4B | — |
| 300878.SZZhejiang Wecome Pharmaceutical Company Limited | $31.89 | +1.24% | $4.5B | — |
| 603439.SSGuiZhou SanLi Pharmaceutical Co.,Ltd | $14.10 | -0.28% | $5.7B | — |
| 603718.SSShanghai Hile Bio-Technology Co., Ltd. | $3.01 | +0.67% | $2.0B | — |
Source: Financial Modeling Prep · peers by sector/industry